Loading organizations...
OmniGuide has raised $60.0M across 3 funding rounds.
Key people at OmniGuide.
OmniGuide has raised $60.0M in total across 3 funding rounds.
OmniGuide Inc. develops advanced energy surgical tools for minimally invasive procedures. Its core offerings include CO2, Thulium, and Holmium laser systems, delivered via proprietary flexible fibers. These precise instruments support robotic-assisted applications, giving surgeons enhanced control and safety across medical specialties.
Founded in 2000 by MIT faculty Yoel Fink, John D. Joannopoulos, and Edwin Thomas, OmniGuide emerged from their research. Their work on photonic bandgap fibers, enabling flexible CO2 laser guidance, provided the foundational insight, overcoming rigid laser delivery limitations.
OmniGuide's surgical solutions are employed by surgeons and hospitals in urology, gynecology, ENT, neurology, and cardiothoracic surgery. The company prioritizes patient safety and improved outcomes through innovative, less invasive therapeutic options. Its vision focuses on advancing surgical precision and broadening laser technology's application for global patient benefit.
OmniGuide has raised $60.0M across 3 funding rounds. Most recently, it raised $15.0M Series F in September 2013.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Sep 1, 2013 | $15M Series F | — | Stata Venture Partners | Announced |
| Apr 1, 2008 | $25M Series E | — | Aphelion Capital, Stata Venture Partners | Announced |
| Aug 1, 2006 | $20M Series D | — | Stata Venture Partners | Announced |
Key people at OmniGuide.
OmniGuide has raised $60.0M in total across 3 funding rounds.
OmniGuide's investors include Stata Venture Partners, Aphelion Capital.
OmniGuide is a private medical‑device company that develops and commercializes flexible CO2 laser systems and multi‑layer polymer fiber delivery technology for minimally invasive and robotic‑assisted surgery, focused on patient safety and precision tissue dissection[1][5]. The company’s product families include flexible CO2 fibers (FlexAssure™/Enhanced Safety Fibers), the BEACON™ advanced energy CO2 laser system, and robotic instrumentation (FlexGuide™ Robotic) intended to extend CO2 laser performance into laparoscopy, ENT, urology and other specialties[2][6].
High‑Level Overview
Origin Story
Core Differentiators
Role in the Broader Tech Landscape
Quick Take & Future Outlook
Quick take: OmniGuide converts a unique MIT photonic‑fiber invention into a differentiated surgical energy platform that could expand CO2 laser use in minimally invasive and robotic surgery, provided the company continues to build clinical evidence and workflow integrations that persuade hospitals and surgeons to adopt its systems[1][6][2].